Can I use an OTC hearing aid for otosclerosis?

Sometimes, but only after a real diagnosis. The NIDCD notes that mild otosclerosis can be treated with a hearing aid that amplifies sound, and OTC devices are built for exactly that use case — a stable, gradual, mild-to-moderate loss. The catch is that otosclerosis causes conductive hearing loss, from bone growth blocking the middle ear rather than inner-ear nerve damage, and OTC devices are designed and marketed around the far more common age-related sensorineural pattern. An audiogram from an audiologist or ENT is what confirms whether your loss is conductive, mixed, or sensorineural, and how big the air-bone gap is — information a self-administered OTC hearing screener doesn't give you.

Does a hearing aid stop otosclerosis from getting worse?

No. A hearing aid, OTC or prescription, only amplifies the sound that's getting blocked — it does nothing to the abnormal bone growth causing the blockage. Per the NIDCD, the only treatment that addresses the underlying bone growth is stapedectomy (or the more common modern variant, stapedotomy) surgery, where a surgeon replaces the fixed stapes bone with a prosthetic device to restore sound conduction. Hearing aids and surgery solve different problems: one compensates for the hearing loss, the other corrects its mechanical cause.

Is surgery or a hearing aid better for otosclerosis?

It depends on the case, but the numbers favor surgery when someone is a reasonable candidate. A prospective comparative study of stapedotomy versus hearing aids found surgery patients had better speech-in-noise recognition, more low-frequency hearing gain, and higher satisfaction scores than hearing aid users, and a related quality-of-life study using the Glasgow Health Status Inventory found the same edge for stapedotomy. Surgery isn't risk-free — one single-institution series reported profound sensorineural hearing loss in 0.21% of stapedotomy patients and non-profound sensorineural loss in 3.2%, plus a revision-surgery rate around 4.5% — which is exactly why an ENT weighs candidacy (commonly a greater than 20 dB air-bone gap) against those risks rather than defaulting straight to the operating room.

What if I'm not a candidate for stapedectomy surgery?

Two main paths, both handled by an audiologist rather than self-fit. A conventional hearing aid can still help with mild-to-moderate loss even without surgery, per the NIDCD. For more advanced conductive or mixed hearing loss where standard amplification isn't enough, a bone conduction hearing device sends sound vibrations through the skull bone directly to the cochlea, bypassing the blocked middle ear entirely — candidacy for these devices generally requires bone-conduction thresholds better than 45 dB HL and a speech discrimination score of 60% or higher. See our best bone conduction hearing aids guide for how that technology works.

Does pregnancy make otosclerosis worse?

It's a widely repeated claim, but the evidence is more contested than most articles let on. Some women report their otosclerosis symptoms first appeared during or after a pregnancy, with self-reported hearing decline around 33% after a single pregnancy in older survey data, and a hormonal theory (rising estrogen affecting bone remodeling) is commonly cited as the mechanism. But a larger 2021 case-control study of 1,196 women found no significant association between a history of pregnancy and how severe otosclerosis was at diagnosis — meaning the pregnancy-acceleration idea is a real, debated hypothesis in the research, not a settled fact. If you're pregnant and notice new hearing changes, that's still worth an ENT visit regardless of which theory turns out to be right.

How common is otosclerosis?

The NIDCD estimates otosclerosis affects more than 3 million Americans, with white, middle-aged women at the highest risk. Onset is typically between the teens and mid-40s, most often first noticed in the 20s or 30s — younger than the age-related hearing loss OTC devices are usually marketed toward. It also tends to run in families, and research has found tinnitus in roughly 72% of otosclerosis patients, a significantly higher rate than in the general population.

Hearing Aid for Otosclerosis: What Actually Works (2026)

Quick Answer: Otosclerosis is abnormal bone growth around the stapes bone in the middle ear that physically blocks sound from reaching the inner ear, causing conductive hearing loss — a different mechanism than the sensorineural, age-related loss most OTC hearing aids are designed around. Per the NIDCD, mild cases can be managed with a hearing aid, but a hearing aid only amplifies sound; it doesn’t stop the bone growth. Stapedectomy (or stapedotomy) surgery is the only treatment that corrects the underlying cause, and comparative research shows it typically outperforms hearing aids on speech-in-noise recognition and patient satisfaction — though it carries a small but real risk of further hearing loss. Anyone suspecting otosclerosis needs an audiogram and ENT evaluation first, since that’s what determines the air-bone gap and whether you’re a hearing aid, surgery, or bone-conduction candidate.

Most hearing aid buying guides — this site’s included — are written around one pattern: a gradual, sensorineural, age-related loss that a self-fitting OTC device can amplify straight out of the box. Otosclerosis doesn’t follow that pattern. The hearing loss is real, but the cause is mechanical, not neural, and that distinction changes which device, if any, actually fixes the problem.

Otosclerosis, by the numbers

More than 3 million Americans are affected by otosclerosis, according to the NIDCD, with white, middle-aged women at the highest risk.
Tinnitus shows up in roughly 72% of otosclerosis patients, per clinical research — a significantly higher rate than in the general population, and often the symptom that prompts someone to get evaluated in the first place.
Surgical candidacy is generally defined by an air-bone gap greater than 20 dB, and one single-institution stapedotomy series reported profound sensorineural hearing loss in 0.21% of patients and non-profound sensorineural loss in 3.2%, with a revision-surgery rate around 4.5%.
Bone conduction hearing device candidacy typically requires bone-conduction thresholds better than 45 dB HL and a speech discrimination score of 60% or higher.

What otosclerosis actually does to your ear

Normal hearing depends on three tiny middle-ear bones — the malleus, incus, and stapes — passing sound vibrations along to the inner ear. In otosclerosis, abnormal bone remodeling causes the stapes to become fixed in place instead of vibrating freely, which blocks sound from getting through. That’s why otosclerosis produces conductive hearing loss rather than the sensorineural loss caused by inner-ear nerve damage: the sound-detecting machinery in the cochlea is intact, but the sound isn’t reaching it. Per the NIDCD, the loss usually starts in one ear and moves to the other over time, often appearing very gradually, and low-pitched sounds are frequently the first to go — which is a different early pattern than the high-frequency loss that typically shows up first with age-related hearing loss.

Why this matters for choosing a hearing aid

OTC hearing aids are built, marketed, and self-fit around a specific assumption: a stable, mild-to-moderate, sensorineural loss, the kind that shows up gradually with age. Otosclerosis technically fits the “mild-to-moderate” and often “gradual” parts of that description, which is part of why the NIDCD says a hearing aid can treat mild cases. But conductive hearing loss behaves differently from sensorineural loss in ways a generic self-fitting profile doesn’t account for — the amount of amplification needed to overcome a mechanical blockage isn’t necessarily the same curve an OTC device calculates from a standard hearing screener built around sensorineural patterns. That gap is exactly why an audiogram matters here more than for typical age-related loss: it’s what tells you (and, ideally, an audiologist) whether you’re dealing with a straightforward conductive loss a hearing aid can manage, a mixed loss, or a case where surgery is the better first move.

Hearing aid vs. stapedectomy vs. bone conduction

Option	What it does	Best for	Trade-off
Conventional hearing aid	Amplifies sound; doesn't touch the bone growth	Mild, stable conductive loss, or anyone declining surgery	Doesn't stop progression; may need reprogramming as the gap widens
Stapedectomy / stapedotomy	Replaces the fixed stapes with a prosthetic, restoring conduction	Confirmed air-bone gap over ~20 dB, good surgical candidate	Small but real risk of further (sensorineural) hearing loss; ~4.5% revision rate
Bone conduction hearing device	Sends sound through skull bone, bypassing the middle ear	Advanced conductive/mixed loss, or not a surgical candidate	Requires a dedicated device, not a standard hearing aid

For someone with a confirmed mild, stable conductive loss who wants to try amplification before considering surgery, a lab-tested OTC pick like the Jabra Enhance Select 300 (also sold under Jabra’s newer M-series naming as the M2, around $1,695/pair) is a reasonable starting point — but it’s still worth confirming with an audiologist that a conventional hearing aid, rather than a bone conduction device, is the right fit for your specific air-bone gap.

Jabra Enhance Select 300 — for confirmed mild, stable conductive loss

~$1,695/pair · self-fitting OTC · 100-day return window

A reasonable first step once an audiologist has confirmed a mild, gradual conductive loss and ruled out a large air-bone gap that would point toward surgery instead.
Not a substitute for the ENT workup — otosclerosis is a case where the diagnosis, not the device, is the hard part.

Check price on Amazon →

Once you’ve got a diagnosis and know which path you’re on, Amazon Prime’s free 30-day trial gets hearing aid accessories or a bone-conduction-compatible headset to your door in two days rather than a week.

Red flags: get an audiogram before you shop

Otosclerosis can’t be self-diagnosed from how muffled things sound — the only way to know whether you’re dealing with conductive, mixed, or sensorineural loss (and how big any air-bone gap is) is a formal hearing test. See an audiologist or ENT promptly if you notice: hearing loss that started in one ear and seems to be spreading to the other; low-pitched sounds becoming harder to hear before high-pitched ones; new or worsening tinnitus; or any hearing change during or after a pregnancy. This article is general information, not medical advice — a proper audiogram is what actually determines which of the options above applies to you.

Best Bone Conduction Hearing Aids — how skull-bone transmission works for conductive and mixed hearing loss that standard amplification can’t reach.
Hearing Aid for Meniere’s Disease — another condition where a hearing aid alone doesn’t address the underlying cause.
OTC vs. Prescription Hearing Aids — the broader decision once you know what type of loss you have.
Hearing Aid vs. Cochlear Implant — the next step for severe-to-profound loss that amplification alone can’t reach.
Hearing Aid Technology Levels Explained — what to look for once you’re confirmed as a hearing aid candidate.

The bottom line

Otosclerosis causes a mechanical, conductive hearing loss — not the sensorineural pattern OTC hearing aids are designed around — so a hearing aid can help with mild, confirmed cases but does nothing to the bone growth actually causing the problem. Get an audiogram and ENT evaluation first; that’s what determines whether a conventional hearing aid, stapedectomy surgery, or a bone conduction device is the right next step, not a self-administered hearing screener.